Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With AML

NCT01592266 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01592266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01592266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With AML
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2012
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leucemia